Inhibitory effect of Acetylshikonin on drug-resistant Candida albicans
Zhenyi Xu, Wenting Zhou, Jiazi Luo, Yuanyuan Dai, Shixian Yang, Shufang Li, Yanqiang Huang · 2026
Read Inhibitory effect of Acetylshikonin on drug-resistant Candida albicans by Zhenyi Xu, Wenting Zhou, Jiazi Luo, Yuanyuan Dai, Shixian Yang, Shufang Li, Yanqiang Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13617698.txt.
Description
Zhenyi Xu and six colleagues report a 2026 study of acetylshikonin, a red naphthoquinone compound from the plant Lithospermum erythrorhizon. Its target is Candida albicans, a yeast that causes everything from thrush to deadly bloodstream infections and increasingly resists standard drugs. The team measured killing power in dishes, then tested the compound in mouse models of vaginal and mouth candidiasis.
Acetylshikonin proved active against drug-resistant strains in the laboratory and in the animals. It weakened the yeast's grip on surfaces, damaged its cell membrane and wall, and pushed cells toward an apoptosis-like death. The compound appears to bind and switch down an enzyme called malate synthase 1, choking a metabolic cycle the yeast needs, which unleashes reactive oxygen species that damage DNA. The authors propose the compound as a candidate worth developing for resistant fungal infections.
Catalog record
| CREATOR | Zhenyi Xu, Wenting Zhou, Jiazi Luo, Yuanyuan Dai, Shixian Yang, Shufang Li, Yanqiang Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58878 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |